Results 151 to 160 of about 38,073 (235)

Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease. [PDF]

Mov Disord
Senkevich K, Parlar SC, Chantereault C, Liu L, Yu E, Rudakou U, Ahmad J, Ruskey JA, Asayesh F, Spiegelman D, Waters C, Monchi O, Dauvilliers Y, Dupré N, Greenbaum L, Hassin-Baer S, Miliukhina I, Timofeeva A, Emelyanov A, Pchelina S, Alcalay RN, Gan-Or Z.   +21 more
europepmc   +1 more source

A Recurrent and Atypical Form of Guillain-Barré Syndrome: A Case Report. [PDF]

Cureus
Ed Dafali L, Semlali S, Lachraf H, Elharrak S, Ech Cherif El Kettani S.   +4 more
europepmc   +1 more source

Forgotten Gangliosides: <i>O</i>-Acetylated and Lactone Gangliosides. [PDF]

Int J Mol Sci
Mauri L, Vaghi S, Sonnino S.
europepmc   +1 more source

Varicella-zoster virus infection triggering GD3 antibody-positive variant Guillain-Barré syndrome: a case report and literature review. [PDF]

BMC Neurol
Wu Y, Gu L, Liu J, Yan W, Wei J.
europepmc   +1 more source

Modeling Tay-Sachs Disease in Astrocyte-like Cells Reveals Significant Changes in the Transcriptomic Profile. [PDF]

Int J Mol Sci
Suárez-García DA, Espejo-Mojica AJ, Alméciga-Díaz CJ.   +2 more
europepmc   +1 more source

Siglec-1-targeting single domain antibodies block or enhance pathogen binding to dendritic cells. [PDF]

J Biol Chem
Brink HJ, Affandi AJ, Man S, Dekker NCCT, Großewichtrup EA, Bouma RG, Toutounchi NS, Konijn VAL, Stolwijk JGC, van Hamme JL, Olesek K, Heijnen DAM, Fish A, Moutsiopoulou A, Celie PHN, Dekkers G, Heukers R, Mastrobattista E, Smit MJ, van Kooyk Y, van Gils MJ, Heikema AP, Kootstra NA, Geijtenbeek TBH, den Haan JMM.   +24 more
europepmc   +1 more source

Dose- and state-dependent enhancement of hippocampal CA1 pyramidal neuron excitability by GM1 ganglioside in male rats with cholinergic lesions. [PDF]

Sci Rep
Ashkavandi S, Moazedi AA, Semnanian S, Abdolahpour S, Gholami M.   +4 more
europepmc   +1 more source

Development of Small-Molecule Allosteric Modulators of Beta-Galactosidase (β-Gal) for the Treatment of GM1 Gangliosidosis and Morquio B. [PDF]

Int J Mol Sci
Pérez-Carmona N, Cubero E, Ruano A, Pons-Vizcarra M, Delgado A, Trapero A, Reves M, Rodríguez-Pascau L, Taylor J, Martinell M, Barril X, García-Collazo AM.   +11 more
europepmc   +1 more source

Potential roles of gangliosides in chemical-induced neurodegenerative diseases and mental health disorders

Frontiers in Neuroscience
Yutaka Itokazu, Yutaka Itokazu, Alvin V. Terry   +2 more
doaj   +1 more source